Comparing the Value of Data Visualization Methods for Communicating Harms in Clinical Trials

Riaz Qureshi, Xiwei Chen, Carsten Goerg, Evan Mayo-Wilson, Stephanie Dickinson, Lilian Golzarri-Arroyo, Hwanhee Hong, Rachel Phillips, Victoria Cornelius, Mara Mc Adams DeMarco, Eliseo Guallar, Tianjing Li

Research output: Contribution to journalReview articlepeer-review

Abstract

In clinical trials, harms (i.e., adverse events) are often reported by simply counting the number of people who experienced each event. Reporting only frequencies ignores other dimensions of the data that are important for stakeholders, including severity, seriousness, rate (recurrence), timing, and groups of related harms. Additionally, application of selection criteria to harms prevents most from being reported. Visualization of data could improve communication of multidimensional data. We replicated and compared the characteristics of 6 different approaches for visualizing harms: dot plot, stacked bar chart, volcano plot, heat map, treemap, and tendril plot. We considered binary events using individual participant data from a randomized trial of gabapentin for neuropathic pain. We assessed their value using a heuristic approach and a group of content experts. We produced all figures using R and share the open-source code on GitHub. Most original visualizations propose presenting individual harms (e.g., dizziness, somnolence) alone or alongside higher level (e.g., by body systems) summaries of harms, although they could be applied at either level. Visualizations can present different dimensions of all harms observed in trials. Except for the tendril plot, all other plots do not require individual participant data. The dot plot and volcano plot are favored as visualization approaches to present an overall summary of harms data. Our value assessment found the dot plot and volcano plot were favored by content experts. Using visualizations to report harms could improve communication. Trialists can use our provided code to easily implement these approaches.

Original languageEnglish (US)
Pages (from-to)55-66
Number of pages12
JournalEpidemiologic Reviews
Volume44
Issue number1
DOIs
StatePublished - 2022

Keywords

  • adverse events
  • controlled clinical trials
  • data visualization
  • drug-related side effects and adverse reactions
  • harms
  • health communication
  • randomized controlled trials

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Comparing the Value of Data Visualization Methods for Communicating Harms in Clinical Trials'. Together they form a unique fingerprint.

Cite this